Biotech uptick moves into March

Biotech uptick moves into March: “February went out like a lion in biotechnology as filings for initial public offerings (IPOs) by three companies capped a flurry of activity in the sector. Acadia Pharmaceuticals, Alnylam Pharmaceuticals, and Ark Therapeutics announced filings in the wake of strong openings on Wall Street last month for GTx, Renovis, Corgentech, […]


Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!